Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Pozycja w akcjach #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Cena akcji
$2.69
Kapitalizacja rynkowa
$40.34M
Zmiana (1 dzień)
-1.47%
Zmiana (1 rok)
-48.27%
Kraj
US
Handel Serina Therapeutics, Inc. (SER)

Kategoria

Historia stopy dywidendy dla Serina Therapeutics, Inc. (SER)
Stopa dywidendy (TTM) dla Serina Therapeutics, Inc. (symbol akcji: SER) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Serina Therapeutics, Inc. (SER) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji